Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: BBM-C101 Injection · Cervical High-Grade Squamous Intraepithelial Lesion(HSIL) Recruitment opened Shanghai Mianyi Biopharmaceutical Co., Ltd.Phase 1/2 NCT07668960
  2. Notable: RO7821657 · Solid Tumors Recruitment opened Hoffmann-La RochePhase 1 NCT07883577
  3. Notable: Mass Balance Study of [¹⁴C]Purinostat Mesylate for Injection in Healthy Participants Recruitment opened Chengdu Zenitar Biomedical Technology Co., LtdPhase 1 NCT07809217
  4. Notable: Post Market Study of the Flexagon Only System and Flexagon Plus OTOLoc for Creation of Side-to-Side Duodeno-Ileal Diversion & Flexagon Plus OTOLoc Self Forming Magnet (SFM) System for Creation of Side-to-Side Jejunum-Jejunum and Ileal-Ileal Anastomoses Recruitment opened GI Windows, Inc.Not applicable NCT07695558
  5. Notable: GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study Recruitment opened Noom Inc.Not specified NCT07588984
  6. Notable: Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy Recruitment opened UNCANCER LLCNot applicable NCT07885033
  7. Notable: Decision Counseling and Follow-up for Shield+ Patients Recruitment opened Guardant Health, Inc.Not specified NCT07620535
  8. Notable: First-Line Lenvatinib in Child-Pugh B · HCC Unsuitable for Curative Treatment Recruitment opened National Cancer Center, KoreaPhase 2 NCT07297654
  9. Notable: Dynamic Magnetic Resonance Imaging of Human Subarachnoid Space Using Intrathecal Gadolinium Contrast Recruitment opened National Institute of Neurological Disorders and Stroke (NINDS)Phase 1 NCT07796360
  10. Notable: PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study Recruitment opened University of FloridaPhase 3 NCT07670650
  11. Notable: Targeting Lifestyle to Improve Colorectal Cancer Screening Recruitment opened Norwegian Institute of Public HealthNot applicable NCT07135115
  12. Notable: Povidone Iodine for Caries Prevention Enrolling by invitation only Jeffrey A. BanasPhase 3 NCT07741409
  13. Notable: Bisphosphonates Combined With Vancomycin · Cierny-Mader Type I and III Osteomyelitis Recruitment opened Second Affiliated Hospital, Zhejiang University, School of MedicinePhase 3 NCT07435051
  14. Notable: Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy Reclassified as terminated (was completed) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not specified NCT05440617
  15. Notable: APBI Re-irradiation Recruitment opened Dartmouth-Hitchcock Medical CenterPhase 1/2 NCT07612254
  16. Notable: SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates Recruitment opened Jules Bordet InstitutePhase 2 NCT07474558
  17. Notable: Folate Study · Advanced Prostate Cancer Recruitment opened University of California, San DiegoPhase 2 NCT06536374
  18. Notable: BNAbs and Anti-PD-1 in HIV Recruitment opened Ole Schmeltz SøgaardPhase 2 NCT07820813
  19. Notable: KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer Recruitment opened Gustave Roussy, Cancer Campus, Grand ParisPhase 2 NCT07622017
  20. Notable: Mochida ReFeel for Digital Nerve Injuries Enrolling by invitation only OrthoCarolina Research Institute, Inc.Phase 4 NCT07524465
  21. Notable: First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma Recruitment opened Annika KurreckPhase 2 NCT07844057
  22. Notable: ASTRAEA · ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation Recruitment opened Stephen ShiaoPhase 2 NCT07015853
  23. Notable: RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) Enrollment reopened University of FloridaPhase 1 NCT07492316
  24. Notable: 68Ga- and 18F-CAIX PET Imaging Study Recruitment opened Peking University First HospitalEarly Phase 1 NCT07875946
  25. Notable: LSD Occupancy of the Serotonin 2A Receptor in the Human Brain Enrollment reopened Copenhagen University Hospital, RigshospitaletEarly Phase 1 NCT05953038